Done sou Salè H1B

Akèy › Kat vèt › Takeda Pharmaceuticals America Inc.

Takeda Pharmaceuticals America Inc.: sponso kat vèt (PERM)

Takeda Pharmaceuticals America Inc. te depoze 4 aplikasyon sètifikasyon travay PERM ki te pran desizyon pandan ane fiskal 2024–2026; sètifye: 3. Mwayèn salè yo ofri $88,900; mwayèn tan soti nan depozisyon jiska sètifikasyon: 480 jou.

Aplikasyon PERM4
Sètifye3
Salè medyan ofri$88,900
Mwayèn jou pou sètifikasyon480
Deja ap travay pou anplwayè a100%
Anplwaye (jan yo depoze)288
Nan biznis depi1998
Adrès anplwayèLexington, MA

Salè H-1B nan Takeda Pharmaceuticals America Inc. →

Tit travay

Tit travayAplikasyon PERMSalè medyan
Associate Director, Analytics & Insights1$145,500
Senior Procurement Experience Agent1$81,900
Global HCM Reporting Specialist1$88,900
Release Train Engineer1—

Kote travay

Okipasyon

Dènye desizyon

Tit travaySalè bazKoteSoumètDesideEstatiJou
Release Train Engineer$137,000–$234,800Cambridge, MANov 13, 2025Nov 17, 2025Retire—
Senior Procurement Experience Agent$81,900–$140,400Exton, PAApr 16, 2024Aug 6, 2025Sètifye477
Associate Director, Analytics & Insights$145,500–$246,000Lexington, MAFeb 28, 2024Jun 25, 2025Sètifye483
Global HCM Reporting Specialist$88,900–$140,400Exton, PAAug 17, 2023Dec 9, 2024Sètifye, ekspiré480

Salè yo se pi ba nivo salè yo ofri nan chak aplikasyon, konvèti an yon montan anyèl; estatistik yo itilize aplikasyon plen tan ki sètifye. Sètifikasyon PERM se yon etap nan direksyon yon kat vèt; USCIS pran desizyon sou petisyon an. Se pa konsèy legal. Sous: Depatman Travay Etazini, Done Divilgasyon OFLC PERM, ane fiskal 2024–2026 (dènye desizyon Jun 30, 2026).